Abstract:Chromatin remodeling enzymes can also have nonhistone roles, broadening their biological functions. It is shown that Kdm3a binding to cellular chaperones in the cytoplasm is relevant for morphogenetic events leading to infertility in enzymatically null mice. This provides evidence that Kdm3a is not just a histone modifier.
“…Interestingly, mouse mutants for the histone N-lysine demethylase Kdm3a (Jmjd1a, Tsga, or Jhdm2a) are obese, predisposed to diabetes (Inagaki et al, 2009;Tateishi et al, 2009), and have male infertility phenotypes (Okada et al, 2007) overlapping with mouse models of dysfunctional cilia. Structural abnormalities of the acrosome and manchette were observed in mutant Kdm3a mouse spermatids (Kasioulis et al, 2014) similar to those reported for conditional inactivation of Ift88 (Kierszenbaum, 2002;San Agustin et al, 2015). KDM3A localizes to the actin-rich acrosome-acroplaxome region, which is altered in Kdm3a mutant spermatids (Kasioulis et al, 2014).…”
Section: Introductionsupporting
confidence: 80%
“…Structural abnormalities of the acrosome and manchette were observed in mutant Kdm3a mouse spermatids (Kasioulis et al, 2014) similar to those reported for conditional inactivation of Ift88 (Kierszenbaum, 2002;San Agustin et al, 2015). KDM3A localizes to the actin-rich acrosome-acroplaxome region, which is altered in Kdm3a mutant spermatids (Kasioulis et al, 2014). In spite of these phenotypic and functional overlaps, a link between KDM3A and ciliogenesis has not been investigated.…”
Section: Introductionsupporting
confidence: 51%
“…More recently, scaffolding and noncatalytic modes of transcriptional regulation by KDM3A have emerged wherein KDM3A binds to the SWI-SNF (Switch-sucrose nonfermentable) chromatin-remodeling complex (Abe et al, 2015) or Hedgehog-responsive transcription factor GLI1 (Schneider et al, 2015), regulating expression of target genes. Although these functions relate to the role of KDM3A in the nucleus, KDM3A exits the nucleus in response to mechanosensitive stimuli (Kaukonen et al, 2016) and is found at various cytoplasmic sites of somatic cells and during germ cell development (Okada et al, 2007;Yang et al, 2009;Yamada et al, 2012;Kasioulis et al, 2014). Altogether, these findings indicate that KDM3A is a multifunctional protein with highly regulated subcellular distributions and nontranscriptional roles that remain to be explored.…”
Yeyati et al. demonstrate that the histone demethylase KDM3A acts as a negative regulator of ciliogenesis by modulating actin dynamics, both transcriptionally and by directly binding actin. KDM3A influences local actin networks to restrict intraflagellar transport during ciliogenesis; in its absence, cilia become unstable with abnormal lengths and accumulated intraflagellar transport proteins.
“…Interestingly, mouse mutants for the histone N-lysine demethylase Kdm3a (Jmjd1a, Tsga, or Jhdm2a) are obese, predisposed to diabetes (Inagaki et al, 2009;Tateishi et al, 2009), and have male infertility phenotypes (Okada et al, 2007) overlapping with mouse models of dysfunctional cilia. Structural abnormalities of the acrosome and manchette were observed in mutant Kdm3a mouse spermatids (Kasioulis et al, 2014) similar to those reported for conditional inactivation of Ift88 (Kierszenbaum, 2002;San Agustin et al, 2015). KDM3A localizes to the actin-rich acrosome-acroplaxome region, which is altered in Kdm3a mutant spermatids (Kasioulis et al, 2014).…”
Section: Introductionsupporting
confidence: 80%
“…Structural abnormalities of the acrosome and manchette were observed in mutant Kdm3a mouse spermatids (Kasioulis et al, 2014) similar to those reported for conditional inactivation of Ift88 (Kierszenbaum, 2002;San Agustin et al, 2015). KDM3A localizes to the actin-rich acrosome-acroplaxome region, which is altered in Kdm3a mutant spermatids (Kasioulis et al, 2014). In spite of these phenotypic and functional overlaps, a link between KDM3A and ciliogenesis has not been investigated.…”
Section: Introductionsupporting
confidence: 51%
“…More recently, scaffolding and noncatalytic modes of transcriptional regulation by KDM3A have emerged wherein KDM3A binds to the SWI-SNF (Switch-sucrose nonfermentable) chromatin-remodeling complex (Abe et al, 2015) or Hedgehog-responsive transcription factor GLI1 (Schneider et al, 2015), regulating expression of target genes. Although these functions relate to the role of KDM3A in the nucleus, KDM3A exits the nucleus in response to mechanosensitive stimuli (Kaukonen et al, 2016) and is found at various cytoplasmic sites of somatic cells and during germ cell development (Okada et al, 2007;Yang et al, 2009;Yamada et al, 2012;Kasioulis et al, 2014). Altogether, these findings indicate that KDM3A is a multifunctional protein with highly regulated subcellular distributions and nontranscriptional roles that remain to be explored.…”
Yeyati et al. demonstrate that the histone demethylase KDM3A acts as a negative regulator of ciliogenesis by modulating actin dynamics, both transcriptionally and by directly binding actin. KDM3A influences local actin networks to restrict intraflagellar transport during ciliogenesis; in its absence, cilia become unstable with abnormal lengths and accumulated intraflagellar transport proteins.
“…Some effects of HSP90 on the cytoskeleton may be mediated by other proteins like the lysine demethylase Kdm3a. Mutant Kdm3a mice display male infertility and their cells show an altered fractionation of actin and tubulin (Kasioulis et al 2014). …”
HSP90AB1 (heat shock protein 90 kDA alpha, class B, member 1), also known as HSP90beta, is a member of the large family of HSPs which function as molecular chaperones. Chaperones, by binding to client proteins, support proper protein folding and maintain protein stability, especially after exposure to various kinds of cellular stress. Client proteins belong to various protein families including kinases, ubiquitin ligases and transcription factors. HSP90 proteins act as dimers and bind clients with the help of co-chaperones. The cochaperones influence many functions including client binding, ATPase activity or ATP binding of HSP90. HSPs are necessary for a large scale of cellular processes and therefore essential for cell survival. Since client proteins can be mutant proteins that would be degraded without the help of chaperones, HSPs also promote tumor formation and cancer cell proliferation. As such, they are also targets for new therapeutic approaches in cancer treatment. This review focuses on recent studies on HSP90AB1, if possible in comparison with its close homologue HSP90AA1.
“…KDM3A is also involved in other cellular processes such as cell cycle, embryonic and adult stem cell renewal, and differentiation of vascular smooth muscle (15). KDM3A has been implicated in the development and progression of several malignancies, including hepatocellular carcinoma and gastric cancer (16, 17).…”
Renal cell carcinoma (RCC), the most common kidney cancer, is responsible for more than 100,000 deaths per year worldwide. The molecular mechanism of RCC is poorly understood. Many studies have indicated that epigenetic changes such as DNA methylation, noncoding RNAs, and histone modifications are central to the pathogenesis of cancer. Histone demethylases (KDMs) play a central role in histone modifications. There is emerging evidence that KDMs such as KDM3A, KDM5C, KDM6A, and KDM6B play important roles in RCC. The available literature suggests that KDMs could promote RCC development and progression via hypoxia-mediated angiogenesis pathways. Small-molecule inhibitors of KDMs are being developed and used in preclinical studies; however, their clinical relevance is yet to be established. In this mini review, we summarize our current knowledge on the putative role of histone demethylases in RCC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.